Global cost-effectiveness of GDM screening and management: current knowledge and future needs.

摘要: Gestational diabetes mellitus (GDM) is an increasing cause of morbidity in women and their offspring. Screening intervention can reduce perinatal most likely also long-term consequences. There have been many economic studies, but not recently systematically compared. We conducted a systematic search abstraction cost-effectiveness cost–utility studies from 2002 to 2014. standardized all findings 2014 US dollars. found that ratios varied widely. Most variation was be due differences geographic setting, diagnostic criteria approaches, outcomes (e.g., inclusion or exclusion type 2 risk associated costs). concluded incorporation benefits GDM screening treatment has huge impact on estimates. Based the large methodological heterogeneity varying results existing body evidence, we find it unreasonable outline any global recommendations. For future recommend adaptation local preferences, as well examination proposed by International Association Diabetes Pregnancy Study Groups (IADPSG).